Spots Global Cancer Trial Database for An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
Official Title: An Open-Label Study Assessing Subject Satisfaction With A-101 Hydrogen Peroxide Topical Solution, 40% (w/w) Treatment for Seborrheic Keratoses of the Face, Neck, and Decolletage
Study ID: NCT03487588
Conditions
Interventions
Study Description
Brief Summary: This study is an open-label study designed to evaluate subject's satisfaction after treatment of seborrheic keratoses with A-101 40%.
Detailed Description:
Keywords
Eligibility
Minimum Age: 30 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Aclaris Investigational Site, Fort Washington, Pennsylvania, United States
Aclaris Investigational Site, Knoxville, Tennessee, United States
Aclaris Investigational Site, Austin, Texas, United States
Contact Details
Name: David Gordon, MD
Affiliation: Aclaris Therapeutics
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
